1. Home
  2. TWI vs WGSWW Comparison

TWI vs WGSWW Comparison

Compare TWI & WGSWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TWI
  • WGSWW
  • Stock Information
  • Founded
  • TWI 1890
  • WGSWW 2017
  • Country
  • TWI United States
  • WGSWW United States
  • Employees
  • TWI N/A
  • WGSWW N/A
  • Industry
  • TWI Steel/Iron Ore
  • WGSWW Retail: Computer Software & Peripheral Equipment
  • Sector
  • TWI Industrials
  • WGSWW Technology
  • Exchange
  • TWI Nasdaq
  • WGSWW Nasdaq
  • Market Cap
  • TWI N/A
  • WGSWW N/A
  • IPO Year
  • TWI 1993
  • WGSWW N/A
  • Fundamental
  • Price
  • TWI $8.79
  • WGSWW $0.25
  • Analyst Decision
  • TWI Strong Buy
  • WGSWW
  • Analyst Count
  • TWI 1
  • WGSWW 0
  • Target Price
  • TWI $11.00
  • WGSWW N/A
  • AVG Volume (30 Days)
  • TWI 666.2K
  • WGSWW 35.4K
  • Earning Date
  • TWI 02-26-2025
  • WGSWW 02-18-2025
  • Dividend Yield
  • TWI N/A
  • WGSWW N/A
  • EPS Growth
  • TWI N/A
  • WGSWW N/A
  • EPS
  • TWI N/A
  • WGSWW N/A
  • Revenue
  • TWI $1,852,563,000.00
  • WGSWW $305,450,000.00
  • Revenue This Year
  • TWI $2.92
  • WGSWW N/A
  • Revenue Next Year
  • TWI N/A
  • WGSWW N/A
  • P/E Ratio
  • TWI N/A
  • WGSWW N/A
  • Revenue Growth
  • TWI N/A
  • WGSWW 50.79
  • 52 Week Low
  • TWI $6.34
  • WGSWW $0.21
  • 52 Week High
  • TWI $14.28
  • WGSWW $0.25
  • Technical
  • Relative Strength Index (RSI)
  • TWI 57.18
  • WGSWW N/A
  • Support Level
  • TWI $8.69
  • WGSWW N/A
  • Resistance Level
  • TWI $9.24
  • WGSWW N/A
  • Average True Range (ATR)
  • TWI 0.35
  • WGSWW 0.00
  • MACD
  • TWI -0.03
  • WGSWW 0.00
  • Stochastic Oscillator
  • TWI 35.24
  • WGSWW 0.00

About WGSWW GeneDx Holdings Corp.

GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.

Share on Social Networks: